Indeed, aberrant expression of BORG in mouse and human breast cancers was associated with the acquisition of breast cancer stem cell-like properties and upregulation of known breast cancer stem cell markers, such as NANOG, ALDH1, and ITGA6/α6Integrin/CD49f. Here, ALDH1A1 is linked to breast carcinoma.